As of November 2024, BrightGene Bio-Medical Technology has a market cap of $1.43B. This makes BrightGene Bio-Medical Technology the world's 6366th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.47B | -29.54% |
2023 | $2.09B | 55.07% |
2022 | $1.35B | -38.52% |
2021 | $2.19B | -19.85% |
2020 | $2.73B | 44.16% |
2019 | $1.90B | - |